Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Director Shareholding

14 Mar 2005 17:00

Ark Therapeutics Group PLC14 March 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF COMPANY ARK THERAPEUTICS GROUP PLC 2) NAME OF DIRECTOR NIGEL PARKER 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them. (If notified) 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary 7) Number of shares/amount of stock acquired 8) Percentage of issued Class 9) Number of shares/amount of stock disposed 10) Percentage of issued Class 11) Class of security 12) Price per share 13) Date of transaction 14) Date company informed 15) Total holding following this notification 16) Total percentage holding of issued class following this notification IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THE FOLLOWING BOXES 17) Date of grant 12 MARCH 2005 18) Period during which or date on which exercisable 75% EXERCISABLE FROM 12 MARCH 2008, REMAINING 25% EXERCISABLE FROM 12 MARCH 2009. OPTIONS LAPSE ON 11 MARCH 2015 19) Total amount paid (if any) for grant of the option NIL 20) Description of shares or debentures involved: class, number. 350,000 ORDINARY SHARES 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 96.25 PENCE PER SHARE 22) Total number of shares or debentures over which options held following this notification 4,196,808 ORDINARY SHARES 23) Any additional information 24) Name of contact and telephone number for queries Nick PlummerCompany Secretary+44 (0)20 7388 7722 25) Name and signature of authorised company official responsible for making this notification Nick PlummerCompany Secretary Date of Notification 14 March 2005 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20078:00 amRNSBlocklisting Interim Review
8th Jun 20078:00 amRNSBlocklisting Interim Review
7th Jun 20077:00 amRNSKerraped Launch
31st May 200710:13 amRNSVoting Rights and Capital
31st May 20077:02 amRNSResearch Update
22nd May 20077:01 amRNSTrinam Update
2nd May 20077:01 amRNSTrinam(R) RAC Application
30th Apr 20074:10 pmRNSVoting Rights and Capital
27th Apr 20077:01 amRNSRegulatory Update
26th Apr 20075:29 pmRNSResult of AGM
24th Apr 20077:01 amRNSResearch Update
2nd Apr 20071:42 pmRNSVoting Rights and Capital
2nd Apr 200712:22 pmRNSAnnual Information Update
30th Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:20 pmRNSBlock Listing Application
15th Mar 20075:37 pmRNSHolding(s) in Company
12th Mar 20072:12 pmRNSHolding(s) in Company
7th Mar 20077:01 amRNSFinal Results
5th Mar 20075:33 pmRNSHolding(s) in Company
1st Mar 200710:40 amRNSVoting Rights and Capital
23rd Feb 20079:00 amRNSHolding(s) in Company
22nd Feb 20077:01 amRNSStroke Patent
16th Feb 20079:00 amRNSHolding(s) in Company
16th Feb 20077:00 amRNSResearch Update
6th Feb 20071:03 pmRNSHolding(s) in Company
5th Feb 20072:41 pmRNSOption Awards
1st Feb 20077:01 amRNSEuropean Grant Awarded
25th Jan 20075:19 pmRNSHolding(s) in Company
22nd Jan 200711:24 amRNSTotal Voting Rights
19th Jan 200712:28 pmRNSNotice of Results
15th Jan 200712:45 pmRNSRe: Award
11th Jan 20077:01 amRNSResearch Update
5th Jan 20077:53 amRNSResearch Update
20th Dec 20062:00 pmRNSHolding(s) in Company
20th Dec 200610:28 amRNSVoting and Rights Capital
18th Dec 20067:01 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSPlacing of Shares
4th Dec 200611:26 amRNSBlocklisting Interim Review
4th Dec 200611:21 amRNSBlocklisting Interim Review
27th Nov 20061:44 pmRNSHolding(s) in Company
13th Oct 20067:00 amRNSCerepro Patent Granted
10th Oct 20067:01 amRNSRe: Kerraboot
2nd Oct 20063:49 pmRNSHolding(s) in Company
27th Sep 20067:01 amRNSResearch Update
8th Sep 20064:11 pmRNSHolding(s) in Company
5th Sep 20067:03 amRNSResearch Update
1st Sep 20067:00 amRNSCerepro EMEA review
30th Aug 20067:01 amRNSInterim Results
23rd Aug 20067:01 amRNSResearch Update
4th Aug 200612:50 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.